Intranasal insulin reduces ADHD-like behaviors and neurodevelopmental deficits following neonatal hypoxia-ischemia in juvenile rats

Neonatal hypoxia-ischemia (HI) is a leading cause of long-term neurodevelopmental impairment and is increasingly associated with a heightened risk of attention-deficit/hyperactivity disorder (ADHD) and related behavioral abnormalities. Beyond its metabolic role, insulin functions as a neurotrophic and immunomodulatory factor in the developing brain. However, whether early enhancement of central insulin signaling can mitigate the neuroinflammatory and behavioral sequelae of HI remains unclear….

via https://pubmed.ncbi.nlm.nih.gov/42600992/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20260826011006&v=2.20.1